Agouron Pharmaceuticals (AGPH) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Agouron Pharmaceuticals (AGPH)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
6136	24	0	AGPH

Emcee: Bhag Karamchandani	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
4586	deserves repeating..... "Some key interaction data between Sustiva and pr	scaram(o)uche	-	6/29/1998
4585	Here's another take on Shionogi licensing news. biz.yahoo.com	sam	-	6/29/1998
4584	News Stories This AM Agouron Says Its HIV Drug Viracept May Work With Reduced	ALL	-	6/29/1998
4583	Rick, I don't think that anyone would say that PIs are not effective. Howe	Henry Niman	-	6/29/1998
4582	Thanks Peter, I knew the numbers were around here somewhere! Personally, I thin	Constant Reader	-	6/29/1998
4581	Randy, PI market penetration in the US is considerably higher than 10% ... her	Peter Singleton	-	6/29/1998
4580	Someone correct me if I am wrong (this is off the top of my head which is often	Constant Reader	-	6/29/1998
4579	As far as "those" analysts, I don't think they have factored in t	margie	-	6/29/1998
4578	Here is the SD Union Tribune article. LOCAL STOCKS Immune Response, Agouron	Gary L. Kepler	-	6/28/1998
4577	Today's San Diego Tribune: "Immune Response, Agouron Pharmaceuticals p	Izzy	-	6/28/1998
4576	That's what I've been saying all along, but I can't justify prescri	Izzy	-	6/28/1998
4575	Hit it hard and hit it early, proven to be the effective course....... only	scaram(o)uche	-	6/28/1998
4574	Rick, excellent article on angiogenesis ... noticed the author had the same na	Peter Singleton	-	6/27/1998
4573	Bill: EntreMed, Sugen, Genentech, Ixsys, Regeneron, ImClone, and a cast of tho	scaram(o)uche	-	6/27/1998
4572	Rick, I have never been particularly impressed with Basu (the junior biotech an	Vector1	-	6/27/1998
4571	>> If 3340 works, and if an agent that inhibits the differentiation o	billkirn	-	6/27/1998
4570	While hunting the web for endostatin information I stumbled across a short repo	Andreas Helke	-	6/26/1998
4569	Very funny. Especially this: "With the stock trading at only 2 times FY	sam	-	6/26/1998
4568	Sort of looks like their boss walked into the office and said "issue an op	scaram(o)uche	-	6/26/1998
4567	Thanks Dennis. Market sentiment in general seems to be caution. Recent n	Steve Fancy	-	6/26/1998
4566	Here is the text of their HOLD rating: PM Call: AGPH: Initiating Coverage With	mod	-	6/26/1998
4565	one more post from the IMNR Yahoo thread ... really worth reading if you've	Peter Singleton	-	6/26/1998
4564	hello all, poaching the below from the outstanding IMNR thread on Yahoo, re: a	Peter Singleton	-	6/26/1998
4563	Peter, this is my (naive) seat of the pants attempt to read Rick's mind on	Pseudo Biologist	-	6/25/1998
4562	If endostatin works as well in humans as it does in mice it will be the most se	Andreas Helke	-	6/25/1998

Go to reply# or date (mm/dd/yy):